Radboudumc, iMM Lisboa, PATH collaborate on first-in-human study of novel malaria vaccine

(Instituto de Medicina Molecular) The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH in Seattle, Wash., announced today that they will collaborate to test a new approach to malaria vaccine development in humans for the first time.
Source: EurekAlert! - Biology - Category: Biology Source Type: news